Ashley Schlafstein

Papers

Total Citations

H-Index

About

Ashley Schlafstein is a surgical oncologist whose research focuses on optimizing treatment outcomes for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). Her most cited work, a 2022 study examining ninety-day mortality following transoral robotic surgery (TORS) versus radiation, leverages the National Cancer Database to provide critical real-world evidence. By analyzing over 4,000 patients with early-stage OPSCC and low comorbidity scores, Schlafstein demonstrated that TORS is associated with a low 90-day mortality rate of approximately 1.1%, comparable to radiation therapy. This finding challenges assumptions from clinical trials and offers surgeons and patients valuable data for shared decision-making. Her research bridges the gap between controlled trial environments and everyday clinical practice, highlighting the importance of population-level outcomes in surgical oncology. With over 6 citations to this landmark paper and a growing portfolio, Schlafstein is establishing herself as a key voice in head and neck cancer care, advocating for evidence-based, patient-centered treatment strategies that prioritize both survival and quality of life.